Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- NA
A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
- Status
- UNKNOWN
- Phase
- PHASE2
Oral AMXT 1501 Dicaprate in Combination With DFMO
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Tissue Collection Research Protocol
- Status
- COMPLETED
- Phase
- N/A
Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of PTS for Patients With Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1